Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment

Annals of Surgery

Volumn 247, Issue 2, 2008, Pages 265-269

  Kuo, Sung Hsin ^a,b   Chen, Li Tzong ^c,d   Wu, Ming Shiang ^a   Lin, Chung Wu ^a   Yeh, Kun Huei ^a,b   Kuo, Kuan Ting ^a   Yeh, Pei Yen ^a,b   Tzeng, Yi Shin ^a,b   Wang, Hsiu Po ^a   Hsu, Ping Ning ^a   Lin, Jaw Town ^a   Cheng, Ann Lii ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; FEMALE; FOLLOW UP; GASTRECTOMY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN GENE; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH; TUMOR BIOPSY; TUMOR CELL;

ADULT; AGED; BIOPSY; COMPLEMENTARITY DETERMINING REGIONS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; STOMACH NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 38549109999     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181582364     Document Type: Article

References (35)

1. Due MQ, Atherton JC. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut. 2006;55:886-893.
2. Isaacson PG, Du MQ. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol. 2005;205:255-274.
3. Chen LT, Lin JT, Tai JJ, et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst. 2005;97:1345-1353.
4. Zucca E, Roggero E, Pileri S. B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumours. Br J Haematol. 1998;100:3-14.
5. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998;16:1916-1921.
6. Martinelli G, Laszlo D, Ferreri AJ, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol. 2005;23:1979-1983.
7. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet. 2001;357:39-40.
8. Liu H, Ye H, Ruskone-Fourmestraux A, et al. T(11;18) is a marker for all stages of gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology. 2002;122:1286-1294.
9. Levy M, Copie-Bergman C, Gamerio C, et al. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol. 2005;23:5061-5066.
10. Salar A, Bellosillo B, Serrano S, et al. Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab. J Clin Oncol. 2005;23:7361-7362.
11. Cogliatti SB, Schmid U, Schumacher U, et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology. 1991;101:1159-1170.
12. Du MQ, Diss TC, Dogan A, et al. Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa. J Pathol. 2000;192:488-493.
13. Kodera Y, Nakamura S, Yamamura Y, et al. Primary gastric B-cell lymphoma: audit of 82 cases treated with surgery and classified according to the concept of mucosa-associated lymphoid tissue lymphoma. World J Surg. 2000;24:857-862.
14. Takahashi I, Maehara Y, Koga T, et al. Role of surgery in the patients with stage I and II primary gastric lymphoma. Hepatogastroenterology. 2002;50:877-882.
15. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol. 1990;136:1153-1164.
16. Cabras AD, Candidus S, Fend F, et al. Biclonality of gastric lymphomas. Lab Invest. 2001;81:961-967.
17. Kuo SH, Chen LT, Wu MS, et al. Differential response to Helicobacter pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach X significance of tumor cell clonality and BCL10 expression. J Pathol. 2007;211:296-304.
18. Zucca E, Bertoni F, Roggero E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med. 1998;338:804-810.
19. Diss TC, Peng H, Wotherspoon AC, et al. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol. 1993;169:291-295.
20. Inagaki H, Okabe M, Seto M, et al. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol. 2001;158:699-706.
21. Kuo SH, Chen LT, Yeh KH, et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol. 2004;22:3491-3497.
22. Yeh KH, Kuo SH, Chen LT, et al. Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). Blood. 2005;106:1037-1041.
23. Bartlett DL, Karpeh MS Jr, Filippa DA, et al. Long-term follow-up after curative surgery for early gastric lymphoma. Ann Surg. 1996;223:53-62.
24. Kodera Y, Yamamura Y, Nakamura S, et al. The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma. Ann Surg. 1998;227:45-50.
25. Rodriguez-Sabjuan JC, Garcia RA, Trugeda S, et al. Do current indications for surgery of primary gastric lymphoma exist? Rev Esp Enferm Dig. 2006;98:180-188.
26. Yoon SS, Coit DG, Portlock CS, et al. The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg. 2004;240:28-37.
27. Guindi M. Role of activated host T cells in the promotion of MALT lymphoma growth. Semin Cancer Biol. 2000;10:341-344.
28. Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology. 2005;128:1579-1605.
29. Kuo SH, Chen LT, Yeh KH, et al. The expression of CD86 on lymphoma cells and increased infiltration of NK cells in tumor tissues are associated with Helicobacter pylori-dependent state of high-grade gastric MALT lymphoma. World J Gastroenterol. 2005;11:4357-4362.
30. Uren AG, O'Rourke K, Aravind L, et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell. 2000;6:961-967.
31. Hosokawa Y, Suzuki H, Nakagawa M, et al. API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-kappa B binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappa B activation. Biochem Biophys Res Commun. 2005;334:51-60.
32. Yeh PY, Kuo SH, Yeh KH, et al. A pathway for TNF-alpha-induced Bcl10 nuclear translocation: Bcl10 is upregulated by NF-kappa B, phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus. J Biol Chem. 2006;281:167-175.
33. Ohmae T, Hirata Y, Maeda S, et al. Helicobacter pylori activates NF-kappaB via the alternative pathway in B lymphocytes. J Immunol. 2005;175:7162-7169.
34. Maes B, Demunter A, Peeters B, et al. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood. 2002;99:1398-1404.
35. Fischbach W, Goebeler-Kolve M, Starostik P, et al. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet. 2002;360:547-548.